嘉事堂(002462) - 2019 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2019 was ¥4,839,082,160.07, representing a 27.73% increase compared to ¥3,788,463,600.14 in the same period last year[8] - Net profit attributable to shareholders was ¥98,737,958.33, up 12.48% from ¥87,784,300.11 year-on-year[8] - Basic earnings per share increased to ¥0.39, reflecting an 11.43% rise from ¥0.35 in the same quarter last year[8] - Net profit for Q1 2019 was CNY 160,508,634.40, up 13.3% from CNY 141,671,151.77 in the same period last year[39] - The company’s basic and diluted earnings per share were both ¥0.21, up from ¥0.17 in the previous period, reflecting a growth of approximately 23.5%[44] - The company’s operating profit for the current period was ¥69,443,157.59, an increase from ¥56,008,431.97 in the previous period, representing a growth of approximately 24.4%[43] - The company’s total profit for the current period was ¥69,444,077.89, compared to ¥55,899,602.76 in the previous period, indicating a year-over-year increase of about 24.2%[43] Cash Flow - The net cash flow from operating activities was -¥50,182,482.22, an improvement of 90.61% from -¥534,629,181.86 in the previous year[8] - The cash and cash equivalents at the end of the reporting period increased by CNY 469.10 million, a growth of 43.43%, mainly due to improved management of accounts receivable and increased cash collection[19] - The total cash inflow from financing activities was ¥1,614,006,347.99, compared to ¥988,952,763.90 in the previous period, showing an increase of about 63.1%[48] - Operating cash inflow totaled CNY 1,509,422,087.31, an increase from CNY 1,342,241,258.84 in the previous year[51] - Net cash flow from operating activities was negative CNY 164,563,895.68, improving from negative CNY 237,601,220.73 year-over-year[51] - Cash inflow from financing activities reached CNY 1,489,669,739.94, compared to CNY 1,269,132,118.90 in the same period last year[52] Assets and Liabilities - Total assets at the end of the reporting period were ¥11,797,198,848.29, an increase of 8.73% from ¥10,850,365,413.55 at the end of the previous year[8] - The total liabilities as of March 31, 2019, were CNY 7.89 billion, an increase from CNY 7.12 billion at the end of 2018, indicating a growth of CNY 773.65 million[30][31] - The total equity as of March 31, 2019, was CNY 3.91 billion, up from CNY 3.73 billion at the end of 2018, representing an increase of CNY 173.18 million[31] - Current assets totaled CNY 3,924,510,008.71, up from CNY 3,602,589,513.05, marking a 9% increase[34] - The total cash and cash equivalents at the end of the period amounted to ¥1,404,768,049.21, up from ¥1,119,988,926.60 at the end of the previous period, marking an increase of about 25.4%[48] Investments and Acquisitions - The company acquired 51% of Zhejiang Jia Shi Tong Han Biotechnology Co., Ltd. for a cash payment of ¥43,758,000.00, with an outstanding payment of ¥35,006,400.00 as of March 31, 2019[17] - The company also purchased 51% of Zhejiang Jia Shi Shang Yang Medical Technology Co., Ltd. for ¥61,200,000.00, with the acquisition cost still pending[18] Expenses - The sales expenses increased by CNY 62.58 million, a growth of 58%, mainly due to increased freight and labor costs associated with business growth[19] - The company incurred research and development expenses of ¥16,536,001.15, which is a significant increase compared to ¥7,401,898.82 in the previous period, indicating a focus on innovation[42] - The investment income decreased by CNY 0.31 million, a decline of 98.24%, primarily due to reduced income from structured deposits[19] Shareholder Information - The net assets attributable to shareholders reached ¥2,595,999,554.00, up 3.95% from ¥2,497,261,595.67 at the end of the last year[8] - The company has pledged 10,650,000 shares, which is 25.43% of the shares held by its largest shareholder, China Youth Industrial Development Corporation[16] Market Strategy - The company plans to continue expanding its market presence and investing in new product development to drive future growth[39]